US 9771337
Neprilysin inhibitors
granted A61KA61K31/4196A61K31/42
Quick answer
US patent 9771337 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4196, A61K31/42, A61K31/4355, A61K31/437